On Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q3 2022 earnings per share (EPS) of $1.61, up 31.97% year over year. Total Eli Lilly & Co earnings for the quarter were $1.45 billion. In the same quarter last year, Eli Lilly & Co's earnings per share (EPS) was $1.22.
As of Q1 2023, Eli Lilly & Co's earnings has grown 1.67% year over year. This is 37.83 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Eli Lilly & Co's earnings in the past year totalled $6.03 billion.
What is LLY's earnings date?
Eli Lilly & Co's earnings date is Invalid Date. Add LLY to your watchlist to be reminded of LLY's next earnings announcement.
What was LLY's revenue last quarter?
On Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q3 2022 revenue of $6.94 billion up 2.49% year over year. In the same quarter last year, Eli Lilly & Co's revenue was $6.77 billion.
What was LLY's revenue growth in the past year?
As of Q1 2023, Eli Lilly & Co's revenue has grown 5.34% year over year. This is 7.03 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Eli Lilly & Co's revenue in the past year totalled $29.24 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.